BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22947189)

  • 1. HLA-E expression in cervical adenocarcinomas: association with improved long-term survival.
    Spaans VM; Peters AA; Fleuren GJ; Jordanova ES
    J Transl Med; 2012 Sep; 10():184. PubMed ID: 22947189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
    Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
    J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix.
    Hong JH; Tsai CS; Wang CC; Lai CH; Chen WC; Lee SP; Chang TC; Tseng CJ
    Chang Gung Med J; 2000 Jul; 23(7):396-404. PubMed ID: 10974754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV subtypes and immunological parameters of cervical cancer in Iceland during two time periods, 1958-1960 and 1995-1996.
    Mikaelsdottir EK; Benediktsdottir KR; Olafsdottir K; Arnadottir T; Ragnarsson GB; Olafsson K; Sigurdsson K; Kristjansdottir GS; Imsland AK; Ogmundsdottir HM; Rafnar T
    Gynecol Oncol; 2003 Apr; 89(1):22-30. PubMed ID: 12694650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
    Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
    Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
    Ye Y; Zhang G; Li Z; Chen B; Zhao H; Yang Y; Wang L; Yao J; Chen X; Huang Y; Lang J; Liu P; Chen C
    Cancer Med; 2023 Oct; 12(19):19617-19632. PubMed ID: 37768092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does histology influence prognosis in patients with early-stage cervical carcinoma?
    Grisaru D; Covens A; Chapman B; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2001 Dec; 92(12):2999-3004. PubMed ID: 11753977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
    Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study.
    Yin KC; Lu CH; Lin JC; Hsu CY; Wang L
    J Formos Med Assoc; 2018 Oct; 117(10):922-931. PubMed ID: 30025761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
    Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY
    Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.
    Spaans VM; Trietsch MD; Peters AA; Osse M; Ter Haar N; Fleuren GJ; Jordanova ES
    PLoS One; 2015; 10(7):e0133670. PubMed ID: 26197069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapy.
    Liu P; Ji M; Kong Y; Huo Z; Lv Q; Xie Q; Wang D; Chen B; Wang H; Cui Z; Wang Q; Bin X; Lang J; Chen C
    BMC Cancer; 2022 Mar; 22(1):326. PubMed ID: 35337279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-tumor histogram analysis of apparent diffusion coefficient for differentiating adenosquamous carcinoma and adenocarcinoma from squamous cell carcinoma in patients with cervical cancer.
    Xiao M; Ma X; Ma F; Li Y; Zhang G; Qiang J
    Acta Radiol; 2022 Oct; 63(10):1415-1424. PubMed ID: 34382429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.